US News & World Report: Immunotherapy and cancer, COVID-19

Immunotherapy for cancer patients with COVID-19 appears safe, a preliminary study suggests.

This form of treatment activates a person’s immune system against cancer.

Researchers have been wary, because many COVID-19 complications result from an overactive immune response that leads to increased production of proteins called cytokines that can cause issues such as respiratory failure.

/University Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.